Join The Pink Agenda for TPA Talks: On the Agenda | Genetics & Fertility on Thursday, June 24 at 6:30 PM ET, for a virtual discussion on the wide-ranging effects of carrying a genetic mutation that increases breast cancer risk, and how having a genetic predisposition to develop the disease or receiving a breast cancer diagnosis can impact fertility-based choices and future family planning.
To purchase tickets and sponsorships, visit https://fundraise.thepinkagenda.org/tpatalks.
100% of your ticket purchase supports lifesaving breast cancer research.
We invite you to join the conversation – visit https://bit.ly/tpatalksquestions2021 to submit a question for our panelists. Questions will be addressed as time permits.
Founder & CEO, The Chick Mission
CEO, Amanda Rice Consulting
Three-Time Cancer Survivor
SUSAN M. DOMCHEK, MD
Executive Director, Basser Center for BRCA at Penn Medicine
Director, MacDonald Women’s Cancer Risk Evaluation Center at Penn Medicine
Basser Professor in Oncology, Penn Medicine
Member, BCRF Scientific Advisory Board
ANN PARTRIDGE, MD, MPH
Vice Chair, Medical Oncology at Dana-Farber Cancer Institute
Founder & Director, Young & Strong Program for Young Women with Breast Cancer at Dana-Farber Cancer Institute
Director, Adult Survivorship Program at Dana-Farber Cancer Institute/Brigham & Women’s Cancer Center
Professor of Medicine, Harvard Medical School
Investigator, BCRF supported by The Pink Agenda
Associate General Counsel, Music Product at Facebook
Co-Chair, Young Leadership Council of the Basser Center for BRCA at Penn Medicine
Partner, BLACK&BRCA Initiative at the Basser Center for BRCA at Penn Medicine
BRCA2 Gene Mutation Carrier & Previvor